Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / American Depositary Shares, each representing one ordinary share, nominal value (pound)0.01 per share
-
Shares outstanding
-
49,720,826
-
Total 13F shares
-
21,536,279
-
Share change
-
+6,162,478
-
Total reported value
-
$1,310,815,461
-
Put/Call ratio
-
58%
-
Price per share
-
$60.87
-
Number of holders
-
97
-
Value change
-
+$386,735,647
-
Number of buys
-
59
-
Number of sells
-
35
Institutional Holders of BICYCLE THERAPEUTICS PLC - American Depositary Shares, each representing one ordinary share, nominal value (pound)0.01 per share (BCYC) as of Q4 2021
As of 31 Dec 2021 BICYCLE THERAPEUTICS PLC - American Depositary Shares, each representing one ordinary share, nominal value (pound)0.01 per share (BCYC) had 97 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 21,536,279 shares of stock of the company.
Largest 10 holders included Ridgeback Capital Investments L.P., TYBOURNE CAPITAL MANAGEMENT (HK) LTD, JANUS HENDERSON GROUP PLC, Point72 Asset Management, L.P., FMR LLC, EVENTIDE ASSET MANAGEMENT, LLC, Deep Track Capital, LP, First Light Asset Management, LLC, SV Health Investors, LLC, and Logos Global Management LP.
This table shows 98 institutional shareholders of the security as of 31 Dec 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.